← All trials
NCT00293228
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2007
- Primary completion
- Mar 1, 2008
- Completion date
- Jun 1, 2009
- First posted
- —
- Last posted
- —
- Enrollment
- 200
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- Government of MexicoLead sponsor
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranOverall official - principal investigator
- Instituto Nacional de Enfermedades RespiratoriasOverall official - principal investigator
- Bill and Melinda Gates FoundationCollaborator
- Wellcome TrustCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.